Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism

COVID-19 is an independent risk factor for pulmonary embolism (PE). Little is known about alteplase therapy in this patient group. A retrospective study analyzed 74 patients with PE and acute respiratory distress syndrome (ARDS) due to COVID-19 who were hospitalized in the intensive care unit in 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliynyk, Oleksandr Valentynovych, Rorat, Marta, Solyarik, Serhij Oleksandrovych, Lukianchuk, Vitaliy Andrijovych, Dubrov, Serhij Oleksandrovych, Guryanov, Vitaliy Hrygorovych, Oliynyk, Yanina Volodymyrivna, Yaroslavskaya, Svitlana Mykolaivna, Szalast, Roman, Barg, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385676/
https://www.ncbi.nlm.nih.gov/pubmed/37515199
http://dx.doi.org/10.3390/v15071513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385676/
https://www.ncbi.nlm.nih.gov/pubmed/37515199
http://dx.doi.org/10.3390/v15071513

Ejemplares similares